News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Lumativa Raises $16.24Min Series A Funding
September 4, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Lumativa AG, a Swiss developer of anti-infectives for women's health, has raised CHF 18 million ($16.24m) in Series A funding.
Twitter
LinkedIn
Facebook
Email
Print
Startups
Europe
MORE ON THIS TOPIC
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
April 23, 2025
·
1 min read
·
Tristan Manalac
Podcast
Makary’s First Interview, US Manufacturing Push and Lilly vs. Novo in Obesity Pill Race
April 23, 2025
·
1 min read
·
Heather McKenzie
C-suite
Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech
April 22, 2025
·
2 min read
·
Annalee Armstrong
Layoff Tracker
Tempest Axes 80% of Workforce
April 22, 2025
·
180 min read
·
BioSpace Editorial Staff
